<html>
<head>
    <script language="JavaScript" src="http://code.jquery.com/jquery-1.4.4.js"></script>
    <script language="JavaScript" src="../js/pie.js"></script>
    <script language="JavaScript" src="../js/browser_adjust.js"></script>
    <script language="JavaScript" src="../js/search.js"></script>


    <script type="text/JavaScript">
    <!--

    var array = [[7.8818151995, "../topics/{stock,_price,_share}.html", "{stock,_price,_share}"], [6.2491832615, "../topics/{product,_candidate,_development}.html", "{product,_candidate,_development}"], [5.8307957355, "../topics/{product,_liability,_claim}.html", "{product,_liability,_claim}"], [4.119865506, "../topics/{regulation,_government,_change}.html", "{regulation,_government,_change}"], [2.7247289724, "../topics/{financial,_litigation,_operation}.html", "{financial,_litigation,_operation}"], [2.7151607844, "../topics/{property,_intellectual,_protect}.html", "{property,_intellectual,_protect}"], [2.6705756482, "../topics/{personnel,_key,_retain}.html", "{personnel,_key,_retain}"], [2.6486369738, "../topics/{product,_market,_service}.html", "{product,_market,_service}"], [1.8482909187, "../topics/{control,_financial,_internal}.html", "{control,_financial,_internal}"], [1.7338301198, "../topics/{customer,_product,_revenue}.html", "{customer,_product,_revenue}"], [1.7193364609, "../topics/{competitive,_industry,_competition}.html", "{competitive,_industry,_competition}"], [1.7114214283, "../topics/{capital,_credit,_financial}.html", "{capital,_credit,_financial}"], [1.6973236875, "../topics/{operation,_international,_foreign}.html", "{operation,_international,_foreign}"], [1.6874652584, "../topics/{acquisition,_growth,_future}.html", "{acquisition,_growth,_future}"]];
    var elements = generate_pie_elements(array);
    var piec = null;
    function init() {
        browser_adjust();
        
        // create pie chart
        piec = new PieChart(elements);
        piec.initialize();

    }

    function highlight(i) {
        piec.highlight(i);
    }
    
    function unhighlight() {
        piec.unhighlight();
    }
    //-->
    </script>

    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    
    <title>1018354--4/19/2007--NEW_YORK_HEALTH_CARE_INC</title>

    <link href="../styling.css" rel="stylesheet" type="text/css">
</head>

<body onLoad="init()">
<div id="navigation">
<hr noshade>
<table><tr>
    <td class="navtext">Browse&nbsp;&#x25B8;</td> 
    <td class="linked"><a>Topics</a>
      <ul> 
        <li><a href="../browse/topic-list.html">List of Terms</a></li> 
        <li><a href="../browse/topic-graph.html">Term Distributions</a></li> 
        <li><a href="../browse/topic-presence.html">Relative Presence</a></li>
      </ul> 
    </td> 
    <td class="linked"><a>Documents</a>
      <ul>
        <li><a href="../browse/doc-graph.html">Topic Distributions</a></li>
      </ul> 
    </td>
    <td class="linked"><a>Terms</a>
      <ul> 
        <li><a href="../browse/term-list.html">List by Frequency</a></li> 
        <li><a href="../browse/term-graph.html">Topic Distributions</a></li> 
       </ul> 
    </td>
    <td class="linked"><a>About</a>
      <ul>
        <li><a href="http://www.cs.princeton.edu/~blei/lda-c/">LDA</a></li>
      </ul> 
    </td>
    
    </td>
    <td></td>
    <td class="searchbar"> Search&nbsp;&#x25B8;</td>
    <td class="searchbar"><input type="text" name="search" size="20" onkeypress="handleKeyPress(event)"><span onclick="doSearch()"></span>
    </td>
</tr></table>
</div>

    <div id="top"></div>

    <h1 id="header">
        <table><tr>
            <td id="title">1018354--4/19/2007--NEW_YORK_HEALTH_CARE_INC</td>
        </tr></table>

        <hr noshade>
    </h1>

    <div id="main">
        <table><tr>
            <td width="210px">
                <table class="dark">
                <tr><td><canvas id="canvas" width="200" height="200"></canvas></td></tr>
                <tr class="title">
                    <td>related topics</td>
                </tr>
                <tr class="list"><td id="{stock,_price,_share}" onmouseover="highlight(0)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{stock,_price,_share}.html'">{stock, price, share}</td></tr>
<tr class="list"><td id="{product,_candidate,_development}" onmouseover="highlight(1)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{product,_candidate,_development}.html'">{product, candidate, development}</td></tr>
<tr class="list"><td id="{product,_liability,_claim}" onmouseover="highlight(2)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{product,_liability,_claim}.html'">{product, liability, claim}</td></tr>
<tr class="list"><td id="{regulation,_government,_change}" onmouseover="highlight(3)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{regulation,_government,_change}.html'">{regulation, government, change}</td></tr>
<tr class="list"><td id="{financial,_litigation,_operation}" onmouseover="highlight(4)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{financial,_litigation,_operation}.html'">{financial, litigation, operation}</td></tr>
<tr class="list"><td id="{property,_intellectual,_protect}" onmouseover="highlight(5)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{property,_intellectual,_protect}.html'">{property, intellectual, protect}</td></tr>
<tr class="list"><td id="{personnel,_key,_retain}" onmouseover="highlight(6)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{personnel,_key,_retain}.html'">{personnel, key, retain}</td></tr>
<tr class="list"><td id="{product,_market,_service}" onmouseover="highlight(7)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{product,_market,_service}.html'">{product, market, service}</td></tr>
<tr class="list"><td id="{control,_financial,_internal}" onmouseover="highlight(8)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{control,_financial,_internal}.html'">{control, financial, internal}</td></tr>
<tr class="list"><td id="{customer,_product,_revenue}" onmouseover="highlight(9)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{customer,_product,_revenue}.html'">{customer, product, revenue}</td></tr>
<tr class="list"><td id="{competitive,_industry,_competition}" onmouseover="highlight(10)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{competitive,_industry,_competition}.html'">{competitive, industry, competition}</td></tr>
<tr class="list"><td id="{capital,_credit,_financial}" onmouseover="highlight(11)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{capital,_credit,_financial}.html'">{capital, credit, financial}</td></tr>
<tr class="list"><td id="{operation,_international,_foreign}" onmouseover="highlight(12)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{operation,_international,_foreign}.html'">{operation, international, foreign}</td></tr>
<tr class="list"><td id="{acquisition,_growth,_future}" onmouseover="highlight(13)" onmouseout="unhighlight()" onclick="window.location.href='../topics/{acquisition,_growth,_future}.html'">{acquisition, growth, future}</td></tr>

                </table>
            </td>

            <td>
                <table class="light">
                <tr class="doc"><td>
                    THE COMPANY OPERATES IN A CHANGING ENVIRONMENT THAT INVOLVES NUMEROUS KNOWN AND UNKNOWN RISKS AND UNCERTAINTIES THAT COULD MATERIALLY AND ADVERSELY AFFECT ITS OPERATIONS. THE FOLLOWING HIGHLIGHTS SOME OF THE FACTORS THAT HAVE AFFECTED, AND/OR IN THE FUTURE COULD AFFECT, ITS OPERATIONS.
Risks Relating to the BioBalance Business
BIOBALANCE IS A DEVELOPMENT STAGE COMPANY, HAS GENERATED NO REVENUES TO DATE AND HAS A LIMITED OPERATING HISTORY UPON WHICH IT MAY BE EVALUATED
FAILURE TO SECURE ADDITIONAL FINANCING WOULD RESULT IN IMPAIRED GROWTH AND INABILITY TO OPERATE.
THE LOSS OF KEY EXECUTIVES OR CONSULTANTS OR THE FAILURE TO HIRE QUALIFIED EMPLOYEES WOULD DAMAGE OUR BUSINESS
THE UNILATERAL RESCISSION OF THE EMERALD SETTLEMENT AGREEMENT MAY RESULT IN FUTURE LITIGATION
BIOBALANCE S PRODUCTS ARE IN DEVELOPMENT AND MAY NOT SATISFY REGULATORY REQUIREMENTS OR BECOME COMMERCIALLY VIABLE
POTENTIAL FAILURE OF PLANNED CLINICAL TRIALS TO PRODUCE STATISTICALLY SIGNIFICANT DATA COULD IMPAIR OUR ABILITY TO OBTAIN REGULATORY APPROVAL AND DEVELOP, MANUFACTURE AND SUCCESSFULLY MARKET OUR PRODUCTS
WE ARE DEPENDENT ON NEW PRODUCTS AND CONTINUED INNOVATION
INTELLECTUAL PROPERTY RIGHTS MAY NOT PROTECT OUR BUSINESS
THE VALIDITY OF PATENTS COVERING PHARMACEUTICAL AND BIOTECHNOLOGICAL INVENTIONS AND THE SCOPE OF INTELLECTUAL PROPERTY CLAIMS MADE UNDER SUCH PATENTS IS UNCERTAIN; FAILURE TO SECURE NECESSARY PATENTS COULD IMPAIR OUR ABILITY TO PRODUCE AND MARKET OUR PRODUCTS
FAILURE TO DEVELOP, OR CONTRACT FOR, AN ADEQUATE SALES AND MARKETING ORGANIZATION, OR PARTNER WITH A LARGER PHARMACEUTICAL COMPANY WOULD RESULT IN THE INABILITY TO MARKET AND SELL OUR PRODUCT.
WE OWN NO MANUFACTURING FACILITIES AND WILL BE DEPENDENT ON THIRD PARTIES TO MAKE OUR PRODUCT
WE WILL BE REQUIRED TO COMPLY WITH GOOD MANUFACTURING PRACTICES
POTENTIAL SIDE EFFECTS OF OUR PRODUCT COULD IMPAIR OUR ABILITY TO CONTINUE CLINICAL TRIALS, OBTAIN REGULATORY APPROVAL, OR SUCCESSFULLY MARKET OUR PRODUCTS
OUR PRODUCTS MAY NOT BE ACCEPTED BY PHYSICIANS, PATIENTS OR THIRD PARTY PAYERS
GOVERNMENT AND PRIVATE INSURANCE PLANS MAY NOT PAY FOR OUR PRODUCTS
WE MAY LOSE ANY TECHNOLOGICAL ADVANTAGE BECAUSE PHARMACEUTICAL RESEARCH TECHNOLOGIES CHANGE RAPIDLY
WE MAY NOT BE ABLE TO PROCURE REQUIRED INSURANCE COVERAGE.
WE MAY BE SUBJECT TO PRODUCT LIABILITY CLAIMS WHICH COULD RESULT IN SIGNIFICANT LOSSES AND ADVERSE PRODUCT PUBLICITY
INTENSE COMPETITION MAY RESULT IN OUR INABILITY TO GENERATE SUFFICIENT REVENUES TO OPERATE PROFITABLY
RISKS RELATING TO THE HOME HEALTHCARE BUSINESS
RECENT RULING REGARDING COMPANIONSHIP SERVICES EXEMPTION MAY IMPACT OUR ABILITY TO PROVIDE HEALTHCARE SERVICES.
WE ARE INDIRECTLY DEPENDENT UPON REIMBURSEMENT BY THIRD-PARTY PAYERS; HEALTHCARE REFORM COULD REDUCE REVENUES
SLOW PAYMENTS AND POSSIBLE BAD DEBTS MAY CAUSE WORKING CAPITAL SHORTAGES AND OPERATING LOSSES.
PROFESSIONAL LIABILITY INSURANCE MAY BECOME INADEQUATE, UNAVAILABLE OR TOO COSTLY.
CHANGES IN FEDERAL AND STATE REGULATION COULD INCREASE COSTS AND REDUCE REVENUES.
INTENSE COMPETITION COULD RESULT IN LOSS OF CLIENTS, LOSS OF PERSONNEL, REDUCED REVENUES AND INABILITY TO OPERATE PROFITABLY
DEPENDENCE ON MAJOR CUSTOMERS AND REFERRAL SOURCES MAY RESULT IN SUBSTANTIAL DECLINES IN REVENUES IF SUCH CUSTOMERS ARE LOST
RISKS RELATING TO OUR COMMON STOCK
POSSIBLE VOLATILITY OF COMMON STOCK MAY RESULT IN LOSSES TO SHAREHOLDERS
OUR DELISTING FROM NASDAQ DUE TO OUR FAILURE TO SATISFY NASDAQ LISTING STANDARDS AND OUR STOCK BEING SUBJECT TO THE PENNY STOCK RULES HAS RESULTED IN REDUCED LIQUIDITY AND LOWER STOCK PRICE
FUTURE ISSUANCES OR SALES OF OUR COMMON STOCK COULD ADVERSELY AFFECT THE MARKET PRICE OF OUR COMMON STOCK AND OUR ABILITY TO RAISE ADDITIONAL CAPITAL
ISSUANCE OF PREFERRED STOCK COULD REDUCE THE VALUE OF COMMON STOCK AND COULD HAVE ANTI-TAKEOVER EFFECTS.
WE HAVE NEVER PAID ANY DIVIDENDS ON OUR COMMON STOCK
SHARES OF OUR COMMON STOCK ISSUED IN CONNECTION WITH OUR ACQUISITION OF BIOBALANCE MAY HAVE BEEN ISSUED WITHOUT COMPLYING WITH CERTAIN STATE SECURITIES LAWS.
<p><a href="http://www.sec.gov/Archives/edgar/data/1018354/0001144204-07-019661.txt">Full 10-K form&nbsp;&#x25B8;</a></p>
                </td></tr>
                </table>
            </td>

            <td width="25%">
                <table class="dark">
                <tr class="title">
                    <td>related documents</td>
                </tr>
                <tr class="list"><td onclick="window.location.href='../docs/911216--9-28-2009--PALATIN_TECHNOLOGIES_INC.html'">911216--9/28/2009--PALATIN_TECHNOLOGIES_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1159036--3-13-2009--HALOZYME_THERAPEUTICS_INC.html'">1159036--3/13/2009--HALOZYME_THERAPEUTICS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1036968--3-18-2008--VAXGEN_INC.html'">1036968--3/18/2008--VAXGEN_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/899426--3-31-2008--CALYPTE_BIOMEDICAL_CORP.html'">899426--3/31/2008--CALYPTE_BIOMEDICAL_CORP</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/727510--2-29-2008--ENZON_PHARMACEUTICALS_INC.html'">727510--2/29/2008--ENZON_PHARMACEUTICALS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1059784--10-15-2007--GENEREX_BIOTECHNOLOGY_CORP.html'">1059784--10/15/2007--GENEREX_BIOTECHNOLOGY_CORP</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1364326--1-5-2010--Pure_Pharmaceuticals_CORP.html'">1364326--1/5/2010--Pure_Pharmaceuticals_CORP</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/873198--4-16-2008--GUARDIAN_TECHNOLOGIES_INTERNATIONAL_INC.html'">873198--4/16/2008--GUARDIAN_TECHNOLOGIES_INTERNATIONAL_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1057377--4-14-2008--SAMARITAN_PHARMACEUTICALS_INC.html'">1057377--4/14/2008--SAMARITAN_PHARMACEUTICALS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1389072--2-28-2008--HeartWare_LTD.html'">1389072--2/28/2008--HeartWare_LTD</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/357097--4-15-2009--ISOLAGEN_INC.html'">357097--4/15/2009--ISOLAGEN_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1030839--2-5-2009--Synovics_Pharmaceuticals.html'">1030839--2/5/2009--Synovics_Pharmaceuticals</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1314102--9-25-2009--pSivida_Corp..html'">1314102--9/25/2009--pSivida_Corp.</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1036968--8-30-2007--VAXGEN_INC.html'">1036968--8/30/2007--VAXGEN_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1396335--2-19-2008--Powersafe_Technology_Corp.html'">1396335--2/19/2008--Powersafe_Technology_Corp</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1159036--3-14-2008--HALOZYME_THERAPEUTICS_INC.html'">1159036--3/14/2008--HALOZYME_THERAPEUTICS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1059784--10-10-2008--GENEREX_BIOTECHNOLOGY_CORP.html'">1059784--10/10/2008--GENEREX_BIOTECHNOLOGY_CORP</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/727510--3-12-2010--ENZON_PHARMACEUTICALS_INC.html'">727510--3/12/2010--ENZON_PHARMACEUTICALS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/3116--3-16-2010--AKORN_INC.html'">3116--3/16/2010--AKORN_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1114872--3-19-2008--MILLENNIUM_CELL_INC.html'">1114872--3/19/2008--MILLENNIUM_CELL_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/885317--3-31-2009--OPHTHALMIC_IMAGING_SYSTEMS.html'">885317--3/31/2009--OPHTHALMIC_IMAGING_SYSTEMS</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1360214--3-31-2010--TRANSDEL_PHARMACEUTICALS_INC.html'">1360214--3/31/2010--TRANSDEL_PHARMACEUTICALS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1084557--3-31-2008--TASKER_PRODUCTS_CORP.html'">1084557--3/31/2008--TASKER_PRODUCTS_CORP</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/724910--5-25-2007--NVE_CORP_-NEW-.html'">724910--5/25/2007--NVE_CORP_/NEW/</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/821536--3-28-2008--HEARUSA_INC.html'">821536--3/28/2008--HEARUSA_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1060888--9-14-2009--LIFEQUEST_WORLD_CORP.html'">1060888--9/14/2009--LIFEQUEST_WORLD_CORP</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1326068--6-30-2008--ENABLE_IPC_CORP.html'">1326068--6/30/2008--ENABLE_IPC_CORP</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/75439--5-17-2010--CytoCore_Inc.html'">75439--5/17/2010--CytoCore_Inc</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/826253--3-25-2008--AURA_SYSTEMS_INC.html'">826253--3/25/2008--AURA_SYSTEMS_INC</td></tr>
<tr class="list"><td onclick="window.location.href='../docs/1450552--12-29-2010--Dafoe_Corp..html'">1450552--12/29/2010--Dafoe_Corp.</td></tr>

                </table>
            </td>
        </tr></table>
    </div>

    <div id="footer">
        <br>
        <hr noshade>
    </div>
</body>
</html>
